Latest Breaking News On - Richard waldron chief financial officer bioatla - Page 1 : comparemela.com

SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the

United statesMccormick placeSan diegoRichard waldronBruce mackle lifesci advisorsBioatla incAmerican society of clinical oncologyMccormick place convention centerConditionally active biologicClinical oncologyAnnual meetingConditionally active biologicsRichard waldron chief financial officer bioatla